CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis

Bohdan B. Khomtchouk, Patrick Sun, Zane A. Maggio, Marc Ditmarsch, John J. P. Kastelein, Michael H. Davidson

Open source

DOI
10.3389/fendo.2024.1359780
Published
2024-06-19
Container
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2024.1359780,
  title = {CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis},
  author = {Bohdan B. Khomtchouk and Patrick Sun and Zane A. Maggio and Marc Ditmarsch and John J. P. Kastelein and Michael H. Davidson},
  year = {2024},
  journal = {Frontiers in Endocrinology},
  doi = {10.3389/fendo.2024.1359780},
  url = {https://doi.org/10.3389/fendo.2024.1359780}
}

RIS

TY  - JOUR
TI  - CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis
AU  - Bohdan B. Khomtchouk
AU  - Patrick Sun
AU  - Zane A. Maggio
AU  - Marc Ditmarsch
AU  - John J. P. Kastelein
AU  - Michael H. Davidson
PY  - 2024
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2024.1359780
UR  - https://doi.org/10.3389/fendo.2024.1359780
ER  - 

APA

Khomtchouk, B. B., Sun, P., Maggio, Z. A., Ditmarsch, M., Kastelein, J. J. P., & Davidson, M. H. (2024). CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1359780

Source records